RLAY EPS Estimates
Relay Therapeutics, Inc.
$17.30
+$0.24(+1.41%)
48
Overall
60
Value
30
Tech
55
Quality
Market Cap
$3.74B
Volume
2.12M
52W Range
$5.85 - $21.27
Target Price
$27.08
RLAY EPS estimates: the consensus estimate for Relay Therapeutics, Inc.'s current fiscal year is -$1.61 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RLAY EPS Estimates
- EPS estimate, current quarter
- $-0.40
- EPS estimate, next quarter
- $-0.37
- EPS estimate, current year
- $-1.61
- EPS estimate, next year
- $-1.62
- EPS growth, 3-year
- +14.66%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.61 |
| 2024 | $-2.36 |
| 2023 | $-2.79 |
| 2022 | $-2.59 |
| 2021 | $-3.82 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLAY | $17.30 | +1.4% | 2.12M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relay Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW